Search Results - Makoto Nagai

Switching to ixekizumab improves adalimumab‐induced interstitial lung disease in patients with psoriatic arthritis: A case report by Hideki Hayashi, Minori Kusakabe, Makoto Nagai, Yasutomo Imai, Kiyofumi Yamanishi

Connect to this object online.

Dupilumab treatment reduces serum SCCA2 levels in patients with atopic dermatitis by Kanako Kita, Yasutomo Imai, Makoto Nagai, Masaru Natsuaki, Nobuo Kanazawa

Connect to this object online.

Dupilumab Effects on Innate Lymphoid Cell and Helper T Cell Populations in Patients with Atopic Dermatitis by Yasutomo Imai, Minori Kusakabe, Makoto Nagai, Koubun Yasuda, Kiyofumi Yamanishi

Connect to this object online.

Monitoring Cellular Movement with Photoconvertible Fluorescent Protein and Single-Cell RNA Sequencing Reveals Cutaneous Group 2 Innate Lymphoid Cell Subtypes, Circulating ILC2 and... by Minori Nakatani-Kusakabe, Koubun Yasuda, Michio Tomura, Makoto Nagai, Kiyofumi Yamanishi, Etsushi Kuroda, Nobuo Kanazawa, Yasutomo Imai

Connect to this object online.

Evaluation of long‐term disease control with dupilumab therapy using the Atopic Dermatitis Control Tool in real‐world clinical practice by Marin Kunimoto, Yasutomo Imai, Masako Matsutani, Minori Nakatani‐Kusakabe, Makoto Nagai, Masaru Natsuaki, Kiyofumi Yamanishi, Nobuo Kanazawa

Connect to this object online.

Copper-induced diurnal hepatic toxicity is associated with Cry2 and Per1 in mice by Sarah Tominaga, Hiroki Yoshioka, Satoshi Yokota, Yosuke Tsukiboshi, Masumi Suzui, Makoto Nagai, Hirokazu Hara, Tohru Maeda, Nobuhiko Miura

Connect to this object online.